MedTech leadership
-
The Leadership Timing Paradox Inside MedTech Scale-Ups
Most MedTech companies do not lose momentum because they chose the wrong leaders. They lose momentum because the company entered a new phase before the leadership structure changed with it. This is the leadership timing paradox. This short video explains why leadership timing risk rarely appears as failure first. It usually appears as lost momentum…
ai, artificial-intelligence, business, clinical to commercial transition leadership, executive alignment medtech scaling, leadership, leadership risk medtech scaleups, leadership timing risk medtech, medtech commercialisation leadership structure, medtech governance readiness, medtech leadership transitions, medtech scaleup governance strategy, phase transition leadership risk, portfolio chair medtech leadership risk, right leader wrong phase medtech, series a medtech leadership readiness, technology
-
When Regulatory Conversations Quietly Rewrite the Strategy
Most MedTech strategies are not rewritten in board meetings. They are rewritten gradually, often almost invisibly, through conversations with regulators that at the time appear to be clarifications rather than decisions. This is not because regulators intend to shape company direction. It happens because evidence-based environments reveal reality step-by-step, and each clarification alters what the…
-
Why Good Boards Are Often Late to the Real Conversation
Most MedTech boards are not late because they are inattentive. They are late because they are responsible. That distinction matters more than it first appears. Boards exist to move organisations forward with confidence, not to reopen every decision once it has been prepared, reviewed, and presented. By the time something reaches the agenda, it is…
-
When Progress Quietly Reduces Your Options
Progress feels a little like driving on a motorway. When the road is clear and the car is moving quickly, it is natural to assume you have plenty of options. After all, you are travelling faster and covering more ground than before. But there is a small paradox in motorway driving that anyone who has…
-
How Boards Misread Technical Risk
When Everything Sounds Reasonable Most boards believe they have good visibility on technical risk. They usually do, just not early enough. In well‑run MedTech organisations, risk almost never shows up as failure first. What it shows up as is reassurance. Milestones are being hit. The team sounds confident when they talk it through. The board…
ai, artificial-intelligence, Board oversight of engineering risk, business, Early vs late technical risk decisions, How boards assess technical risk in MedTech, How MDR and IVDR exposed governance gaps, Leadership alignment MedTech, MedTech board governance, MedTech board oversight, MedTech technical risk, Regulatory risk MedTech, Technical leadership risk, Technical risk governance, Technical risk in regulated healthcare, Technical risk visibility at board level, technology, Why MedTech boards miss early technical risk
Harun Rabbani 